Cyclin-dependent kinase 4
Cyclin-dependent kinase 4 (924-932) is a synthetic peptide fragment derived from the C-terminal region of the CDK4 protein, a serine/threonine kinase that plays a pivotal role in regulating the cell cycle. This peptide encompasses amino acids 924 to 932, corresponding to a sequence region often utilized in biochemical and molecular biology research to probe kinase function, substrate specificity, and protein-protein interactions. As a representative segment of CDK4, it serves as a valuable molecular tool for investigating the structural and functional dynamics of cyclin-dependent kinases, which are central to cell proliferation and growth control. The well-defined sequence and biochemical properties of this peptide make it highly relevant for researchers focusing on cell cycle regulation, signal transduction, and kinase-targeted studies.
Kinase substrate specificity studies: As a defined peptide substrate, the 924-932 fragment is widely employed in assays designed to elucidate the substrate preferences of CDK4 and related kinases. Researchers use this peptide to investigate phosphorylation events, enabling the identification of key residues involved in kinase recognition and activity. Such studies are crucial for mapping consensus motifs and understanding the molecular determinants that govern kinase-substrate interactions, which in turn inform the development of selective inhibitors and modulators.
Antibody generation and validation: The unique sequence of the CDK4 (924-932) peptide is frequently used as an immunogen for the production of sequence-specific antibodies. These antibodies can then be employed in various immunoassays, including Western blotting, immunoprecipitation, and immunofluorescence, to detect endogenous or recombinant CDK4. Utilizing this peptide in antibody development enhances specificity, minimizes cross-reactivity, and supports the accurate detection of CDK4 in complex biological samples.
Protein-protein interaction mapping: The 924-932 peptide fragment serves as a molecular probe in studies aimed at characterizing protein-protein interactions involving CDK4. By employing this peptide in pull-down assays, surface plasmon resonance, or other biophysical techniques, investigators can assess the binding affinities and interaction partners of the C-terminal region. Such applications are instrumental in dissecting the regulatory networks that modulate CDK4 function and in identifying novel interaction motifs relevant to cell cycle control.
Peptide-based assay development: The defined sequence and biochemical stability of the CDK4 (924-932) peptide make it an ideal standard for developing and optimizing peptide-based assays. These assays are employed to measure kinase activity, screen for small-molecule modulators, or quantify phosphorylation events in vitro. Incorporating this peptide as a substrate or control enables robust, reproducible assay performance, facilitating high-throughput screening and mechanistic enzymology studies.
Epitope mapping and structural studies: Researchers utilize the 924-932 peptide to delineate epitope regions recognized by antibodies or interacting proteins. By mapping the minimal binding sequence, scientists gain insights into the structural determinants of molecular recognition and specificity. Such information is essential for rational antibody design, structural biology investigations, and the development of peptide-based tools to modulate or interrogate CDK4 function in cellular systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More